Hard-soled Shoe Versus Short Leg Walking Cast for a Fifth Metatarsal Avulsion Fracture: A Randomized Multicenter Noninferiority Trial

October 11, 2015 updated by: Hyong Nyun Kim, Hallym University Kangnam Sacred Heart Hospital

Fifth metatarsal avulsion fractures are common and can usually be treated conservatively. Symptomatic care consisting of protected weightbearing in a hard-soled shoe, air-cast walking boot, or below-knee walking cast have been successful. Several papers reported that early rehabilitation may decrease ankle stiffness, muscle and bone atrophy, and aids in early return to activities. However, early motion of the ankle joint may have the risk of displacement of the fifth metatarsal avulsion fractures. However, studies using hard-sole shoe for protected weightbearing and allowing motion of the ankle joint had successful results. Clapper et al. compared the results of hard-soled shoe and walking cast for a fifth metatarsal avulsion fracture and reported that all avulsion fractures healed uneventfully and that the results were similar between the two. However, this was not a randomized controlled trial.

Devices such as air-cast walking boot, plaster slipper, or Jone's dressing can also be used for the treatment. However, we decided to compare results of hard-soled shoe and short leg walking cast for the treatment of a fifth metatarsal avulsion fracture.

We hypothesized that the 100mm visual analogue scale (VAS) assessed on 6 months after a fifth metatarsal avulsion fracture treated with protected weightbearing in a hard-soled shoe is not inferior to protected weightbearing in a short leg walking cast but is superior to short leg walking cast with respect to time to return to normal daily life and patient's satisfaction.

Study Overview

Detailed Description

This study is a noninferiority, randomized controlled trial of patients presenting to multiple centers. The primary outcome measure is the 100mm VAS assessed on 6 months after a fifth metatarsal avulsion fracture. 100mm VAS was compared between the experimental group (hard-soled shoe) and the control group (short leg walking cast) on 6 months follow-up examination. The 100mm VAS is widely used self assessment tool for evaluating pain after fracture. The secondary objectives were to determine whether hard-soled shoe was superior to short leg walking cast with respect to time until return to normal daily life and patient's satisfaction.

The sample size was determined using methods appropriate for noninferiority trials, assuming 90% power and a significance level of 0.05. We performed a pilot study on 18 patients and assessed 100mm VAS on 6 months. Pooled standard deviation was 16.6. To find out whether the hard-soled shoe is not inferior to short leg walking cast for a fifth metatarsal avulsion fracture, 74 patients were required to have 90% power that the lower limit of an one-sided 95% confidence interval for the difference between two treatments will be above the noninferiority margin of -10. We assumed the drop-out rate to be 20%. Adding this number, 96 patients were required for the study.

Determination of the noninferiority margin was based on clinical significance. Todd et al. reported on a study of 48 patients that the minimum clinically significant difference of 100mm VAS was 13mm and that differences of less than this amount, even if statistically significant, are unlikely to be of clinical significance. We decided that the noninferiority margin at 10 mm difference which is less than this amount will be adequate to prove noninferiority of the experiment group (hard-soled shoe) over the control group (short leg walking cast).

After 1 weeks of immobilization in a short leg posterior splint, patients are randomized to experiment group (hard-soled shoe) and control group (short leg walking cast). Randomization was stratified by the study centers. Block randomization were used and the investigators were blinded to the block sizes being used to ensure allocation concealment. Delayed union was defined as a lack of bridging callus on 3 of 5 cortices at 12 weeks. Nonunion was defined as lack of cortical bridging or a clearly visible fracture line, at 14 weeks post injury.

If a subject had discontinued prior to completion of 6 months, the last observation was carried forward for the intent-to-treat analysis. Subjects who crossed over to the other treatment arm, for an example, patients in experiment group(hard-soled shoe) who changed to short leg walking cast or in control group (short leg walking cast) who changed to hard-soled shoe, were analyzed according to their initial group allocation for the intent-to-treat analysis. Additionally, an as-treated (per-protocal) analysis was also conducted on patients who completed the 6 months follow-up with the protocol assigned.

Although previous studied have not documented an increase risk of reduction loss with protected weightbearing in a hard-soled shoe protocol, a safety rule was put in place to assure patients, clinicians, and the health research ethics board that the safety of our patients was a priority. Reduction loss was not a primary outcome, but it was monitored carefully regardless of published evidence. A safety rule established a priori eliminated any dissent among the research team and participating surgeons about stopping the study in the event of an apparent adverse outcome related to protected weightbearing in a hard-soled shoe. If a difference of greater than three spontaneous reduction loss occurred between the groups, the intervention would be halted. A reduction loss or metal failure was defined as one that occurred without patient instigation of inappropriate activity. The reduction loss was to be monitored by study personnel not involved in the outcome assessment.

Study Type

Interventional

Enrollment (Anticipated)

96

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Seoul, Korea, Republic of, 150-950
        • Recruiting
        • Kangnam Sacred Heart Hospital, Hallym University College of Medicine
        • Principal Investigator:
          • Hyong Nyun Kim, MD, PhD
        • Contact:
    • Gyeongi
      • Gunpo, Gyeongi, Korea, Republic of, 435-040
        • Recruiting
        • Sanbon Hospital, Wonkwang University College of Medicine
        • Contact:
      • Seongnam, Gyeongi, Korea, Republic of, 463-712
        • Recruiting
        • CHA Bundang Medical Center, CHA University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • age between 18 and 65 years
  • fifth metatarsal avulsion fracture

Exclusion Criteria:

  • open fractures
  • pathologic fractures
  • a fifth metatarsal avulsion fracture combined with other lower extremity injuries such as Lisfranc injury
  • patients with diabetes or neuroarthropathy
  • patients with obesity (BMI >30, weight >100 kg)
  • any other conditions that are expected to prevent the patients from following the study protocol

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: short leg walking cast
After 1 weeks of immobilization in a short leg posterior splint, patient is allowed protected weightbearing in a short leg walking cast
Patients allocated to control group are allowed tolerable weightbearing in a short leg walking cast after one week of immobilization in a posterior splint
Experimental: hard-soled shoe
After 1 weeks of immobilization in a short leg posterior splint, patient is allowed tolerable weightbearing in a hard-soled shoe
Patients allocated to experiment group are allowed tolerable weightbearing in a hard-soled shoe after one week of immobilization in a posterior splint

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
100mm visual analogue scale (VAS)
Time Frame: 6 months after a fifth metatarsal avulsion fracture
The 100mm VAS is widely used self assessment tool for evaluating pain after fracture.
6 months after a fifth metatarsal avulsion fracture

Secondary Outcome Measures

Outcome Measure
Time Frame
Time to return to preinjury activity
Time Frame: upto 6 months
upto 6 months
patients' subjective satisfactions
Time Frame: 3, 5, 8, 12 weeks and 6 months after injury
3, 5, 8, 12 weeks and 6 months after injury

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Hyong Nyun Kim, MD, PhD, Kangnam Sacred Heart Hospital, Hallym University College of Medicine
  • Study Director: Hyong Nyun Kim, MD, PhD, Kangnam Sacred Heart Hospital, Hallym University College of Medicine

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2014

Primary Completion (Anticipated)

January 1, 2016

Study Completion (Anticipated)

January 1, 2017

Study Registration Dates

First Submitted

January 29, 2014

First Submitted That Met QC Criteria

January 29, 2014

First Posted (Estimate)

January 31, 2014

Study Record Updates

Last Update Posted (Estimate)

October 14, 2015

Last Update Submitted That Met QC Criteria

October 11, 2015

Last Verified

October 1, 2015

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Treatment

3
Subscribe